
Thymia is a London-based global health technology company founded in 2020, focused on making mental health objectively measurable and monitorable using AI-powered assessments. Their technology uniquely combines voice, video, and behavioral data through gamified activities and advanced AI models to identify and measure mental health conditions and symptoms with high accuracy. Thymia offers two main product suites: Helios for mental wellness indicators like stress and burnout, and Apollo for clinical insights into conditions such as depression, anxiety, and ADHD. Their solutions are embedded via APIs or plugins, serving providers, payors, employers, and clinicians worldwide. With over 41,000 individuals assessed, 20+ partnerships, and 11 proprietary AI models, thymia is recognized as a top scaleup and has extensive scientific publications and press coverage, positioning it as a leader in AI-driven mental health diagnostics and monitoring.

Thymia is a London-based global health technology company founded in 2020, focused on making mental health objectively measurable and monitorable using AI-powered assessments. Their technology uniquely combines voice, video, and behavioral data through gamified activities and advanced AI models to identify and measure mental health conditions and symptoms with high accuracy. Thymia offers two main product suites: Helios for mental wellness indicators like stress and burnout, and Apollo for clinical insights into conditions such as depression, anxiety, and ADHD. Their solutions are embedded via APIs or plugins, serving providers, payors, employers, and clinicians worldwide. With over 41,000 individuals assessed, 20+ partnerships, and 11 proprietary AI models, thymia is recognized as a top scaleup and has extensive scientific publications and press coverage, positioning it as a leader in AI-driven mental health diagnostics and monitoring.
Headquarters: London, United Kingdom
Founded: 2020
Core product: AI-powered voice and multimodal biomarkers for mental health (Helios, Apollo)
Customers / use cases: Providers, payors, employers, clinicians; mental health assessment & monitoring
Employees: 29
Total funding (reported): USD 5,560,000
Objective measurement and monitoring of mental health and related physiological signals using voice and multimodal AI.
2020
Health technology / Digital mental health
Pre-seed round reported
Seed round reported with Kodori AG named as lead investor
Equity crowdfunding round reported
“Kodori AG and Crowdcube are listed among investors; multiple investors reported (9–10)”